All Topic Areas
1 - 10 of 684 more >>
Articles
1 - 5 of 21 more >>
- Drug-Resistant Seizures Often Take Years to Develop
While about 80 percent of people with epilepsy gain significant relief from drug therapy, the remaining 20 percent have seizures that cannot be controlled by medications. Many of these people have a particular type of epilepsy called partial epilepsy. A new study shows that people with partial epilepsy often have seizures controlled by medications for years before their seizures become drug-resistant. The study also found that periods when seizures stopped for a year or more are common in these...
National Institutes of Health
- FDA Approves First New Drug Application for Treatment of Radiation Contamination due to Cesium or Thallium
This is a revised version of FDA Press Release P03-75, originally issued earlier on Oct. 2, 2003. Corrections were made to the original version, which is now obsolete. The Food and Drug Administration (FDA) today approved a New Drug Application for Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination, due to harmful levels of cesium-137 or thallium. Radiogardase capsules contain Ferric (III) hexacyanoferrate(II). The approval of Radiogardase is part of...
U.S. Food and Drug Administration
- FDA Approves New Drug for Advanced Prostate Cancer
The Food and Drug Administration (FDA) today approved the New Drug Application (NDA) that permits marketing of Plenaxis (abarelix), a drug for advanced prostate cancer for patients who have no alternative therapy. The drug, indicated for the treatment of the symptoms of men with advanced prostate cancer who cannot take other hormone therapies and who have refused surgical castration, will be marketed under a voluntary risk management program (RMP) agreed to and administered by the sponsor that...
U.S. Food and Drug Administration
- Pregnancy and the Drug Dilemma
By Michelle Meadows Jennifer, 25, of Baltimore wishes she only had to deal with the basics of pre-pregnancy planning, like going for a routine checkup and taking prenatal vitamins. "I get discouraged when I think of how much more I have to consider before trying to conceive," says Jennifer, who has taken the antidepressant Zoloft (sertraline) for three years. She and her husband plan to try for a baby soon, but the questions feel overwhelming. Should Jennifer stop taking the antidepressant?...
U.S. Food and Drug Administration
- FDA Approves First Drug for Rare Type
of Cancer
The Food and Drug Administration (FDA) today approved Alimta (pemetrexed disodium) for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma-a rare type of cancer. Alimta received a priority review and is designated as an orphan drug. It is the first drug approved for this condition. Cancer of the mesothelium, a membrane that covers and protects most of the internal organs of the body is rare; about 2,000 new cases are diagnosed in the United States...
U.S. Food and Drug Administration
Organizations
1 - 5 of 30 more >>
- Drug Digest - http://www.drugdigest.org/
- Drug Card -
- U.S. Food and Drug Administration - http://www.fda.gov/
- Food and Drug Administration -
- Drug Enforcement Administration -
News
1 - 5 of 8507 more >>
- Prostate Cancer: Radiation Not Best
WebMD - Mon, 26 Feb 2007 07:49 EST
- External Radiation for Prostate Cancer May Have Lower Survival Rate
WebMD - Mon, 26 Feb 2007 12:00 EST
- Some prostate cancer treatments better than others
Reuters - Mon, 26 Feb 2007 07:27 EST
- AARP: Prescription Drug Prices Up
WebMD - Tue, 06 Mar 2007 12:00 EST
- Report faults FDA drug-safety tracking system: WSJ
Reuters - Mon, 05 Mar 2007 03:15 EST
Clinical Trials
1 - 5 of 1031 more >>
- Imaging of Cannabinoid Receptors Using New Radioactive Tracer
ClinicalTrials.gov Identifier: NCT00450021 - Recruiting
Healthy
- Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
ClinicalTrials.gov Identifier: NCT00459849 - Active, not recruiting
Uveal Melanoma
- Treatment of M.Graves With Radioactive Iodine: Follow-up Study
ClinicalTrials.gov Identifier: NCT00525122 - Not yet recruiting
Hyperthyroidism
- Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00534196 - Recruiting
Prostate Cancer
- Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
ClinicalTrials.gov Identifier: NCT00342693 - Recruiting
Thyroid Abnormalities

Not Signed In -

